Detalhe da pesquisa
1.
Autologous transplant vs chimeric antigen receptor T-cell therapy for relapsed DLBCL in partial remission.
Blood
; 139(9): 1330-1339, 2022 03 03.
Artigo
Inglês
| MEDLINE | ID: mdl-34570879
2.
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Br J Haematol
; 202(1): 116-121, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37096954
3.
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
Blood
; 137(23): 3291-3305, 2021 06 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33657221
4.
Neighborhood poverty and pediatric allogeneic hematopoietic cell transplantation outcomes: a CIBMTR analysis.
Blood
; 137(4): 556-568, 2021 01 28.
Artigo
Inglês
| MEDLINE | ID: mdl-33104215
5.
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
Haematologica
; 108(7): 1900-1908, 2023 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36779595
6.
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica
; 108(1): 150-160, 2023 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35443559
7.
Long-term outcomes in patients with Burkitt lymphoma older than 65 years: an analysis of the Texas Cancer Registry.
Ann Hematol
; 102(10): 2753-2763, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37422592
8.
Long term outcomes in older patients with primary central nervous system lymphoma: an analysis of the Texas Cancer Registry.
Ann Hematol
; 102(5): 1111-1120, 2023 May.
Artigo
Inglês
| MEDLINE | ID: mdl-36922432
9.
Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma.
Am J Hematol
; 98(1): 140-147, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35567778
10.
African Americans with translocation t(11;14) have superior survival after autologous hematopoietic cell transplantation for multiple myeloma in comparison with Whites in the United States.
Cancer
; 127(1): 82-92, 2021 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32966625
11.
Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Cancer
; 127(4): 609-618, 2021 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33085090
12.
Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation.
Br J Haematol
; 194(1): 145-157, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34124796
13.
Infection risks in multiple myeloma: a systematic review and meta-analysis of randomized trials from 2015 to 2019.
BMC Cancer
; 21(1): 730, 2021 Jun 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34172037
14.
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM).
Eur J Haematol
; 107(6): 602-608, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-34378251
15.
Health Care Reimbursement, Service Utilization, and Outcomes among Medicare Beneficiaries with Multiple Myeloma Receiving Autologous Hematopoietic Cell Transplantation in Inpatient and Outpatient Settings.
Biol Blood Marrow Transplant
; 26(4): 805-813, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-31917269
16.
Optimal Donor for African Americans with Hematologic Malignancy: HLA-Haploidentical Relative or Umbilical Cord Blood Transplant.
Biol Blood Marrow Transplant
; 26(10): 1930-1936, 2020 10.
Artigo
Inglês
| MEDLINE | ID: mdl-32649981
17.
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 26(8): 1459-1468, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32434056
18.
Collection of Peripheral Blood Progenitor Cells in 1 Day Is Associated with Decreased Donor Toxicity Compared to 2 Days in Unrelated Donors.
Biol Blood Marrow Transplant
; 26(6): 1210-1217, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32088366
19.
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research Study.
Biol Blood Marrow Transplant
; 26(3): 472-479, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31669399
20.
Predictors of Loss to Follow-Up Among Pediatric and Adult Hematopoietic Cell Transplantation Survivors: A Report from the Center for International Blood and Marrow Transplant Research.
Biol Blood Marrow Transplant
; 26(3): 553-561, 2020 03.
Artigo
Inglês
| MEDLINE | ID: mdl-31726205